You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 189 A clear increase in TILs and modest tumor growth inhibition by pembrolizumab in prostate cancer tumors growing in bone of CD34+ engrafted NOG mice

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
189 A clear increase in TILs and modest tumor growth inhibition by pembrolizumab in prostate cancer tumors growing in bone of CD34+ engrafted NOG mice

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202084010
Dec 20202005
Jan 20214008
Feb 20211203
Mar 20212607
Apr 20211103
May 2021803
Jun 2021004
Jul 2021006
Aug 20210010
Sep 2021006
Oct 202118021
Nov 202122014
Dec 20211203
Jan 20221201
Feb 20221201
Mar 2022602
Apr 20223206
May 20222004
Jun 20223002
Jul 20221000
Aug 20223404
Sep 20221602
Oct 20221200
Nov 20221006
Dec 20221001
Jan 2023800
Feb 20232400
Mar 20232602
Apr 2023801
May 20231002
Jun 2023600
Jul 20232002
Aug 2023200
Sep 2023200
Oct 20231404
Nov 20232402
Dec 20232800
Jan 20241800
Feb 20241400
Mar 20241201
Apr 20241200
May 20241700
Jun 20242000
Jul 20241201
Aug 20241001
Sep 20241401
Oct 20241205
Nov 20241002
Dec 2024404
Jan 2025803
Feb 2025002
Mar 2025003
Apr 2025003
May 2025003
Jun 2025002
Total7920176